IDEAYA Biosciences (IDYA) Reports Q4 Loss of $0.18/sh

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.18), versus ($0.53) reported last year. Revenue for the quarter came in at $10.57 million, versus $0 reported last year.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'